Idebenone for the Preventive Treatment of Migraine

NCT04151472 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Migraine Disorders
Headache Disorders

Interventions

DRUG: Placebo
DRUG: 90mg Idebenone
DRUG: 270mg Idebenone

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University